{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:07:41Z","timestamp":1781086061373,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1257-6","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T13:05:10Z","timestamp":1551186310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya\u00ae (EVG\/COBI\/FTC\/TAF) and simvastatin; a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Rita","family":"Godinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Bugnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezija","family":"Gracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-7396","authenticated-orcid":false,"given":"James","family":"Tataw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"issue":"1","key":"1257_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13256-015-0671-z","volume":"9","author":"V Suttels","year":"2015","unstructured":"Suttels V, Florence E, Leys J, Vekemans M, Van den Ende J, Vlieghe E, et al. A 68-year old male presenting with rhabdomyolysis-associated acute kidney injury following concomitant use of elvitegravir\/cobicistat\/emtricitabine\/tenofovir disoproxil fumarate and pravastatin\/fenofibrate: a case report. J Med Case Rep. 2015 Dec 8;9(1):190.","journal-title":"J Med Case Rep."},{"issue":"8","key":"1257_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3109\/0886022X.2013.817316","volume":"35","author":"LR Spiegel","year":"2013","unstructured":"Spiegel LR, Schrier PB, Shah HH. Severe recurrent rhabdomyolysis-induced acute kidney injury in a HIV-infected patient on antiretroviral therapy. Ren Fail. 2013 Sep 25;35(8):1186\u201390.","journal-title":"Ren Fail."},{"issue":"3","key":"1257_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00005792-198205000-00002","volume":"61","author":"PA Gabow","year":"1982","unstructured":"Gabow PA, Kaehny WDKS. The spectrum of rhabdomyolysis. Med. 1982;61(3):141.","journal-title":"Med."},{"key":"1257_CR4","doi-asserted-by":"crossref","unstructured":"Miller ML. Clinical manifestations and diagnosis of rhabdomyolysis. UpToDate, Wolters Kluwer. 2017. https:\/\/www.uptodate.com . Accessed 19 Sept 2017.","DOI":"10.1097\/01.COT.0000526658.02326.98"},{"issue":"6","key":"1257_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/mus.21465","volume":"40","author":"J Robinson-Papp","year":"2009","unstructured":"Robinson-Papp J, Simpson DM. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve. 2009 Dec;40(6):1043\u201353.","journal-title":"Muscle Nerve."},{"issue":"1","key":"1257_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12882-017-0656-9","volume":"18","author":"SH Koubar","year":"2017","unstructured":"Koubar SH, Estrella MM, Warrier R, Moore RD, Lucas GM, Atta MG, et al. Rhabdomyolysis in an HIV cohort: epidemiology. causes and outcomes. BMC Nephrol. 2017 Dec 17;18(1):242.","journal-title":"causes and outcomes. BMC Nephrol."},{"issue":"2","key":"1257_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 Aug;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther."},{"key":"1257_CR8","doi-asserted-by":"crossref","unstructured":"Miller ML. Causes of rhabdomyolysis. UpToDate, Wolters Kluwer. 2017. v https:\/\/www.uptodate.com . Accessed 19 Sept 2017.","DOI":"10.1097\/01.COT.0000526658.02326.98"},{"issue":"9","key":"1257_CR9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1592\/phco.20.13.1066.35033","volume":"20","author":"SR Penzak","year":"2000","unstructured":"Penzak SR, Chuck SKSG. Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection. Pharmacotherapy. 2000;Sep;20(9):1066\u201371.","journal-title":"Pharmacotherapy."},{"issue":"10","key":"1257_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s40262-013-0075-4","volume":"52","author":"B Chauvin","year":"2013","unstructured":"Chauvin B, Drouot S, Barrail-Tran A, Taburet A-M. Drug\u2013Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors. Clin Pharmacokinet. 2013 Oct 24;52(10):815\u201331.","journal-title":"Clin Pharmacokinet."},{"issue":"5","key":"1257_CR11","first-page":"721","volume":"19","author":"R Lima","year":"2008","unstructured":"Lima R, Junior G, Liborio A, Daher E. Acute Kidney Injury due to Rhabdomyolysis. Saudi J Kidney Dis Transpl. 2008;19(5):721\u20139.","journal-title":"Saudi J Kidney Dis Transpl."},{"issue":"7","key":"1257_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","volume":"26","author":"R Scherzer","year":"2012","unstructured":"Scherzer R, Estrella M, Li Y, Choi AI, Deeks SG, Grunfeld C, et al. Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS. 2012 Apr;26(7):867\u201375.","journal-title":"AIDS."},{"key":"1257_CR13","first-page":"1367","volume":"12","author":"A-S Sauvage","year":"2016","unstructured":"Sauvage A-S, Darcis G, Moutschen M. Actualit\u00e9 th\u00e9rapeutique dans le VIH\u00a0: le t\u00e9nofovir alaf\u00e9namide. Rev Med Suisse. 2016;12:1367\u20139.","journal-title":"Rev Med Suisse."},{"issue":"10","key":"1257_CR14","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1681\/ASN.2012080857","volume":"24","author":"J Tourret","year":"2013","unstructured":"Tourret J, Deray G, Isnard-Bagnis C. Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword? J Am Soc Nephrol. 2013 Oct 1;24(10):1519\u201327.","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"1257_CR15","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/ckj\/sfw104","volume":"9","author":"P Campos","year":"2016","unstructured":"Campos P, Ortiz A, Soto K. HIV and kidney diseases: 35 years of history and consequences. Clin Kidney J. 2016 Dec;9(6):772\u201381.","journal-title":"Clin Kidney J."},{"key":"1257_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/354908","volume":"2011","author":"B Fernandez-Fernandez","year":"2011","unstructured":"Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Ni\u00f1o MD, Izquierdo MC, Poveda J, et al. Tenofovir Nephrotoxicity: 2011 Update. AIDS Res Treat. 2011;2011:1\u201311.","journal-title":"AIDS Res Treat."},{"issue":"9987","key":"1257_CR17","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","volume":"385","author":"PE Sax","year":"2015","unstructured":"Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. Lancet. 2015 Jun;385(9987):2606\u201315.","journal-title":"Lancet."},{"issue":"2","key":"1257_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/QAI.0000000000001344","volume":"75","author":"F Raffi","year":"2017","unstructured":"Raffi F, Orkin C, Clarke A, Slama L, Gallant J, Daar E, et al. Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. JAIDS J Acquir Immune Defic Syndr. 2017 Jun;75(2):226\u201331.","journal-title":"JAIDS J Acquir Immune Defic Syndr."},{"issue":"3","key":"1257_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/15284336.2017.1291867","volume":"18","author":"FA Post","year":"2017","unstructured":"Post FA, Yazdanpanah Y, Schembri G, Lazzarin A, Reynes J, Maggiolo F, et al. Efficacy and safety of emtricitabine\/tenofovir alafenamide (FTC\/TAF) vs. emtricitabine\/tenofovir disoproxil fumarate (FTC\/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomi. HIV Clin Trials. 2017 May 4;18(3):135\u201340.","journal-title":"HIV Clin Trials."},{"issue":"1","key":"1257_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13054-016-1353-y","volume":"20","author":"JF Doyle","year":"2016","unstructured":"Doyle JF, Forni LG. Acute kidney injury: short-term and long-term effects. Crit Care. 2016 Dec 4;20(1):188.","journal-title":"Crit Care."},{"key":"1257_CR21","doi-asserted-by":"crossref","unstructured":"Bellosta S. Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions. Circulation [Internet]. 2004 Jun 15;109(23_suppl_1):III-50-III-57. Available from: http:\/\/circ.ahajournals.org\/cgi\/doi\/10.1161\/01.CIR.0000131519.15067.1f","DOI":"10.1161\/01.CIR.0000131519.15067.1f"},{"issue":"2","key":"1257_CR22","first-page":"134","volume":"66","author":"A Marot","year":"2011","unstructured":"Marot A, Morelle J, Chouinard VA, Jadoul M, Lambert M, Demoulin N. Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: A case report and review of the literature. Acta Clin Belg. 2011;66(2):134\u20136.","journal-title":"Acta Clin Belg."},{"key":"1257_CR23","doi-asserted-by":"crossref","unstructured":"Stolbach A, Paziana K, Heverling H, Pham P. A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products. J Med Toxicol [Internet]. 2015 Sep 3;11(3):326\u2013341. Available from: http:\/\/link.springer.com\/10.1007\/s13181-015-0465-0","DOI":"10.1007\/s13181-015-0465-0"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1257-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1257-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1257-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T17:03:24Z","timestamp":1663002204000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1257-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1257-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"12 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"69"}}